amniotic suspension
Biologicalexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Dec 14, 2020 (NCT04636229)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07223892 | Phase 3 | Jan 1, 2026 | Carbon Life Sciences |
| NCT06000410 | Phase 3 | Sep 6, 2023 | Organogenesis |
| NCT04698265 | N/A | Jan 1, 2021 | Kaohsiung Medical University |
| NCT04636229 | Phase 3 | Dec 14, 2020 | Organogenesis, Premier Research Group |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Organogenesis | For profit | 2 | 2 | 1 | 2020 |
| Carbon Life Sciences | For profit | 1 | 1 | 1 | 2026 |
| Kaohsiung Medical University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Premier Research Group | For profit | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1